CLINICAL_TRIALS
trial_result
· 2022-11-04
Clinical Trial Update: Ivermectin-artemisinin Combination Therapy for Eradication of Malaria [Phase 4]
Summary
A Phase 4 clinical trial evaluating an ivermectin-artemisinin combination for malaria eradication is ongoing, with the status currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Makerere University | Conditions: Malaria | Phase 4 | Status: UNKNOWN